User profiles for Ahmed Elsharkawy

Ahmed Elsharkawy

- Verified email at uhb.nhs.uk - Cited by 7188

Ahmed Elsayed ElSharkawy

- Verified email at med.tanta.edu.eg - Cited by 151

Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production

…, T Sakurai, S Kim, S Maeda, KH Kim, AM Elsharkawy… - Science, 2007 - science.org
Hepatocellular carcinoma (HCC), the most common liver cancer, occurs mainly in men.
Similar gender disparity is seen in mice given a chemical carcinogen, diethylnitrosamine (DEN). …

[PDF][PDF] Nuclear factor‐κB and the hepatic inflammation‐fibrosis‐cancer axis

AM Elsharkawy, DA Mann - Hepatology, 2007 - Wiley Online Library
Nuclear factor‐κB (NF‐κB) is a transcriptional regulator of genes involved in immunity,
inflammatory response, cell fate, and function. Recent attention has focused on the …

[HTML][HTML] The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology

…, M Maschmeier, D Semela, L Elkrief, A Elsharkawy… - Journal of …, 2020 - Elsevier
Background & Aims Acute decompensation (AD) of cirrhosis is defined as the acute
development of ascites, gastrointestinal hemorrhage, hepatic encephalopathy, infection or any …

Multigenerational epigenetic adaptation of the hepatic wound-healing response

…, QM Anstee, MJ Barter, S Masson, AM Elsharkawy… - Nature medicine, 2012 - nature.com
We investigated whether ancestral liver damage leads to heritable reprogramming of hepatic
wound healing in male rats. We found that a history of liver damage corresponds with …

[HTML][HTML] PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis

…, M Maschmeier, D Semela, L Elkrief, A Elsharkawy… - Journal of …, 2021 - Elsevier
Background & Aims Acute decompensation (AD) of cirrhosis may present without acute-on-chronic
liver failure (ACLF) (AD-No ACLF), or with ACLF (AD-ACLF), defined by organ failure(…

[HTML][HTML] The micro-elimination approach to eliminating hepatitis C: strategic and operational considerations

…, JF Dillon, MH El-Sayed, AM Elsharkawy… - Seminars in liver …, 2018 - thieme-connect.com
The introduction of efficacious new hepatitis C virus (HCV) treatments galvanized the World
Health Organization to define ambitious targets for eliminating HCV as a public health threat …

[HTML][HTML] The NF-κB p50: p50: HDAC-1 repressor complex orchestrates transcriptional inhibition of multiple pro-inflammatory genes

AM Elsharkawy, F Oakley, F Lin, G Packham… - Journal of …, 2010 - Elsevier
BACKGROUND & AIMS: The pro-inflammatory functions of NF-κB must be tightly regulated
to prevent inappropriate tissue damage and remodelling caused by activated inflammatory …

[HTML][HTML] Antifibrotic therapy in nonalcoholic steatohepatitis: time for a human-centric approach

PN Brennan, AM Elsharkawy, TJ Kendall… - Nature Reviews …, 2023 - nature.com
Nonalcoholic steatohepatitis (NASH) might soon become the leading cause of end-stage
liver disease and indication for liver transplantation worldwide. Fibrosis severity is the only …

[PDF][PDF] Extracorporeal cellular therapy (ELAD) in severe alcoholic hepatitis: a multinational, prospective, controlled, randomized trial

…, S Rossi, A Parikh, A ElSharkawy… - Liver …, 2018 - Wiley Online Library
Severe alcoholic hepatitis (sAH) is associated with a poor prognosis. There is no proven
effective treatment for sAH, which is why early transplantation has been increasingly discussed. …

Ribavirin for hepatitis E virus infection after organ transplantation: a large European retrospective multicenter study

…, RA De Man, E Cassuto, AM Elsharkawy… - Clinical Infectious …, 2020 - academic.oup.com
Background Ribavirin is currently recommended for treating chronic hepatitis E virus (HEV)
infection. This retrospective European multicenter study aimed to assess the sustained …